Effect of mindfulness-based cognitive therapy on quality of Life , emotional symptom , dimensions of pain , dispositional mindfulness and disease activity in patients with inflammatory bowel disease

Kashan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新: 2020年4月21日

适应症

试验速览

暂无简介。

•Having informed consent to participate in research
•- Age 18-60 years
•- Confirmed diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) (by a physician)
•- Patients should be in the active phase of IBD disease (Mild to moderate, moderate to severe) , not in the remission ,that accompanied by a decrease in symptoms
•- In the Anxiety, Depression, Stress DASS-21 questionnaire, the individual's score on the depression scale of 10 or higher and / or on the anxiety scale of 8 or higher and / or on the stress scale of 15 or higher
•- Ability to do light exercise (for example, to lift arms above the head or bend knees) because part of the practices in the program require this movement
•- Able to commit to attend the eight sessions (participants should consider their personal circumstances to assess if this is practical and feasible for them)
•- To be able to commit to do home practice of up to 45 minutes daily over the 8 weeks of the study (this is a core component of the program)
•- No change of antidepressants (dose or type) within the last 3 months

•- Major psychiatric illness.(The treatment for a major psychiatric illness may interfere with the program)
•- Active alcohol or drug dependency
•-Scheduled for major surgery in the next 3 months
•- Participation in a pharmacological study or psychological intervention study within the last 6 months or intention to participate in a pharmacological study during the duration of this study
•- Have recently (within the last 3 months) been prescribed antidepressants
•- Exacerbation of symptoms and need for change in IBD medication (dose or type) during the study

发起方